title: Ruxolitinib withdrawal syndrome leading to tumor lysis.
authors.affiliation: Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY.
authors.forename: Tong
authors.initials: T
authors.lastname: Dai
authors.forename: Ellen W
authors.initials: EW
authors.lastname: Friedman
authors.forename: Stefan K
authors.initials: SK
authors.lastname: Barta
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors* / Q000235:genetics; D009154:Mutation; D009570:Nitriles; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011720:Pyrazoles / Q000009:adverse effects*; D011743:Pyrimidines; D015275:Tumor Lysis Syndrome / Q000209:etiology*
chemical_list: D009570:Nitriles; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; C507924:JAK2 protein, human; D053614:Janus Kinase 2